Concordance of driver mutations in primary and matched metastasis from patients with non-small cell lung cancer (NSCLC) using next-generation sequencing (NGS).

被引:0
|
作者
Vignot, Stephane
Frampton, Garrett
Yelensky, Roman
Brambilla, Christian
Toffart, Anne-Claire
Miller, Vincent A.
Palmer, Gary A.
Cronin, Maureen T.
Lazar, Vladimir
Soria, Jean-Charles
Stephens, Philip
Brambilla, Elisabeth
机构
[1] Inst Gustave Roussy, INSERM, U981, F-94805 Villejuif, France
[2] Fdn Med, Cambridge, MA USA
[3] CHU Albert Michallon, INSERM, U823, Grenoble, France
[4] Inst Gustave Roussy, Unite Genom Fonct, Villejuif, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7529
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Detection of driver mutation heterogeneity in patients with non-small cell lung cancer (NSCLC) using next generation sequencing (NGS)
    Chilingirova, N.
    Balabanski, L.
    Kurteva, G.
    Toncheva, D.
    Damyanov, D.
    Chilingirov, P.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S612 - S613
  • [2] Use of next-generation sequencing (NGS) to study the impact of demographic variables on prevalence of driver mutations in non-small cell lung cancer (NSCLC).
    Choi, WonSeok William
    Haroun, Faysal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
    Cruz Castellanos, P.
    Rosas Alonso, R.
    Ozaez, I.
    Hernandez, I.
    Losantos, I.
    Gutierrez Sainz, L.
    Higuera Gomez, O.
    Rodriguez Antolin, C.
    Esteban Rodriguez, I.
    Ibanez de Caceres, I.
    de Castro Carpeno, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S558 - S558
  • [4] A Pathology Group Experience with Targeted Next-Generation Sequencing (NGS) for Non-Small Cell Lung Cancer (NSCLC)
    Xu, D.
    Zhang, M.
    Keenan, S. O.
    Coleman, R.
    Tevis, A. Larson
    Rushford, C.
    Christensen, T.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1226 - 1226
  • [5] Clinical and economic benefits of using next-generation sequencing (NGS) in the diagnostics of patients with non-small cell lung cancer with rare mutations
    Stencel, Katarzyna
    Wasag, Bartosz
    Pruszko, Cezary
    Dabrowska, Krystyna
    Ksiazek, Pawel
    Dziadek, Karolina
    Bryl, Maciej
    Krzakowski, Maciej
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (03): : 201 - 208
  • [6] Variant Detection and Tumor Mutational Burden (TMB) Concordance in Blood and Tumor Tissue Using Next-Generation Sequencing (NGS) in Patients with Non-small Cell Lung Cancer (NSCLC)
    Baden, J.
    Chang, H.
    Greenawalt, D. M.
    Kirov, S.
    Pant, S.
    Seminara, A.
    Srinivasan, S.
    Green, G.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1170 - 1170
  • [7] Detecting driver mutations by AmoyDx 11-gene PCR with high concordance with next-generation sequencing in Chinese non-small cell lung cancer patients
    Lin, D.
    Xi, Y.
    Meng, H.
    Feng, Q.
    Lian, S.
    Gao, N.
    Guo, J.
    Yang, X.
    Deng, S.
    Li, M.
    Gai, F.
    Zhu, C.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S722 - S723
  • [8] Concordance of MET Amplification between Fluorescence In Situ Hybridization (FISH) and Next-Generation Sequencing (NGS) in Non-Small Cell Lung Carcinoma (NSCLC)
    Ren, Rongqin
    Shiller, Michelle
    Chandra, Pranil
    Crawford, Eric
    Coldren, Christopher
    Yin, Lihui
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S1654 - S1654
  • [9] Clinical Next-Generation Sequencing in Patients with Non-Small Cell Lung Cancer
    Hagemann, Ian S.
    Devarakonda, Siddhartha
    Lockwood, Christina M.
    Spencer, David H.
    Guebert, Kalin
    Bredemeyer, Andrew J.
    Al-Kateb, Hussam
    Nguyen, TuDung T.
    Duncavage, Eric J.
    Cottrell, Catherine E.
    Kulkarni, Shashikant
    Nagarajan, Rakesh
    Seibert, Karen
    Baggstrom, Maria
    Waqar, Saiama N.
    Pfeifer, John D.
    Morgensztern, Daniel
    Govindan, Ramaswamy
    [J]. CANCER, 2015, 121 (04) : 631 - 639
  • [10] Application of next-generation sequencing (NGS) to reveal target:able genomic alterations (GA) in patients with non-small cell lung cancer (NSCLC).
    Barinov, Alexey
    Gagarin, Ilya
    Demidova, Irma
    Savelov, Nikita
    Grinevich, Vyacheslav
    Stroyakovskiy, Danill
    Popov, Mihail
    Makhson, Anatoly
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)